X

New Eye Disease Treatments to be Developed and Marketed by Allergan, Molecular Partners Combo

by Thilaka Ravi on  August 22, 2012 at 11:04 AM Drug News   - G J E 4
A -A +
US-based Allergan and Switzerland's Molecular Partners announced Tuesday their exclusive alliance to develop and market eye disease treatments worth up to 1.4 billion dollars (1.1 billion euros).
New Eye Disease Treatments to be Developed and Marketed by Allergan, Molecular Partners Combo
New Eye Disease Treatments to be Developed and Marketed by Allergan, Molecular Partners Combo

In addition to $62.5 million in upfront payments, Molecular Partners "is eligible to receive additional success-based payments, including up to $1.4 billion" for meeting development, regulatory and sales goals, as well as royalties on sales, the companies said in a statement.

A first agreement is for cooperation on developing a treatment for age-related macular degeneration, a common cause of vision loss.

A second agreement is for the development of similar compounds that could treat other ophthalmic diseases.

Allergan will have three options to exclusively licence compounds developed out of their collaboration, paying Molecular Partners a fee and taking over further development and marketing.

Zurich-based Molecular Partners is a privately-owned biotech company focusing on the research, development and commercialisation of small proteins called DARPins.

Allergan, the maker of the popular anti-wrinkle treatment Botox, has more than 10,000 employees in more than 100 countries.

Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
User Avatar
* Your comment can be maximum of 2500 characters
Notify me when reply is posted I agree to the terms and conditions

Most Popular News on Medindia

P
M
X

Ask an Expert

Ask an Expert+
s
Statin Therapy can Cut Risk of Pancreatitis
 Statin Therapy can Cut Risk of Pancreatitis
S  Study Says Fewer Circumcisions Could Cost the US Billions
Study Says Fewer Circumcisions Could Cost the US ...